bpc-157 vs bpc-157 + kpv blend

bpc-157 (A-tier) vs bpc-157 + kpv blend (A-tier). mechanism, trials, evidence boundaries, dosing literature. side-by-side reference.

bpc-157 · tier A

the contested repair peptide. strong animal data, thin human trials, huge community gravity.

the contested repair peptide. 200+ rat studies with consistent tissue-repair signals. zero published controlled human RCTs in tendon or injury recovery.

200+ rodent · 0 RCTs · half-life short (minutes IV) · healing

bpc-157 + kpv blend · tier A

gut and systemic anti-inflammatory repair. bpc-157 carries the blend, kpv adds the NF-kB anti-inflammatory leg. strong mechanism, thinner human proof on the second component.

a gut-and-repair pairing built on the strongest component in the gray-peptide world plus a clean anti-inflammatory tripeptide. BPC-157 carries the grade; KPV adds the inflammation leg.

no blend RCT component-derived · half-life BPC-157: short (minutes IV); KPV: short in plasma, stable in GI tract · healing

at a glance

• bpc-157: tier A · 200+ rodent · 0 RCTs
• bpc-157 + kpv blend: tier A · no blend RCT component-derived

reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.